The objective of this study was to establish a model for predicting the molecular subtype of isocitrate dehydrogenase mutation combined with O6-methylguanine-DNA methyltransferase promoter methylation in gliomas using a noninvasive radiomics model based on preoperative MRI. This evidence concerns the gene IDH3A and central nervous system cancer.